Stock Market Today, March: CytomX Surges on Positive Data
CytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
Why Do We Adjust Index Divisor covers the core reasons behind adjustments, including corporate actions and market events, and how they affect benchmarks.
20,620 articlesCytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
When TOI releases earnings, investors watch more than headline numbers. This guide breaks down TOI earnings, what dri...
Symbotic's shiny narrative has investors buzzing, but the biggest gains often hinge on real execution, not just optim...
Carvana stock has faced a rough start to 2026, with the headline move being a sizable drop. This guide breaks down wh...
Oil markets jump on Middle East disruption fears, signaling durable upside for energy stocks. Analysts outline who co...
Realty Income just announced a $1 billion joint venture with Apollo, expanding its real estate platform and preservin...
Lululemon faces renewed headwinds as leadership shifts and governance questions surface. This comprehensive look brea...
Can Trump Media outpace the broader market? This in-depth analysis breaks down the business model, risks, and the sig...
A steep 2026 selloff has investors weighing Microsoft through a new lens. This guide breaks down the case for microso...
AI is advancing beyond chips. NVIDIA's networking revenue just signals a broader shift to end-to-end AI infrastructur...
Gemini Space Station stock has faced a sharp weekly drop as analysts trim targets after a mixed earnings update. This...
A stock that’s fallen dramatically yet still pays a solid dividend invites careful scrutiny. Here’s a practical, numb...